A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

Oncogene

Volumn 18, Issue 14, 1999, Pages 2335-2341

  Strathdee, G ^a   MacKean, M J ^a   Illand, M ^a   Brown, R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Cisplatin; Drug resistance; Methylation; Mismatch repair; Ovarian cancer

Indexed keywords

AZACITIDINE; CISPLATIN; DNA; DNA BINDING PROTEIN;

ALLELE; ARTICLE; BASE MISPAIRING; CANCER CELL CULTURE; CONTROLLED STUDY; DNA METHYLATION; DNA REPAIR; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0033535612     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202540     Document Type: Article

References (25)

1. Aaltonen LA, Peltomaki P, Leach PS, Sistonen P, Pylkkanen L, Maklin J, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B and de la Chapelle A. (1993). Science, 260, 812-815.
2. Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R and Howell SB. (1996). Cancer Res., 56, 3087-3090.
3. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J and Lindblom A. (1994). Nature, 368, 258-261.
4. Brown R, Hirst GL, Gallagher WM, McIlwrath AJ, Margison GP, van der Zee AG and Anthoney DA. (1997). Oncogene, 15, 45-52.
5. Eshleman JR and Markowitz SD. (1995). Curr. Opin. Oncol., 7, 83-89.
6. Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehme A, Christen RD and Howell SB. (1996). Cancer Res., 56, 4881-4886.
7. Fink D, Nebel S, Aebi S, Nehme A and Howell SB. (1997). Int. J Oncol., 11, 539-542.
8. Fink D, Aebi S and Howell SB. (1998). Clin. Cancer Res., 4, 1-6.
9. Frost P, Abbruzzese JL, Hunt B, Lee D and Ellis M. (1990). Cancer Res., 50, 4572-4577.
10. Fujita M, Enomoto T, Yoshino K, Nomura T, Buzard GS and Inoue M. (1995). Int. J. Cancer, 64, 361-366.
11. Hatta Y, Wada M, Takeuchi S, Tasaka T, Lee E, Lee YY, Kim BK, Bang Y, Lee S, Yamada Y, Tomonaga M, Wilczynski SP, Said JW and Koeffler HP. (1997). Int.J. Oncol., 11, 465-469.
12. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JJ, Markowitz S, Willson JKV, Hamilton SR, Kinzler KW, Kane MF, Kolodner RD, Vogelstein B, Kunkel TA and Baylin SB. (1998). Proc. Natl. Acad. Sci. USA, 95, 6870-6875.
13. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM and Kolodner R. (1997). Cancer Res., 57, 808-811.
14. Kaye SB. (1996). Ann. Oncol., 7, 9-13.
15. King BL, Carcangiu ML, Carter D, Kiechle M, Pfisterer J, Pfleiderer A and Kacinski BM. (1995). Br. J. Cancer, 72, 376-382.
16. Liu B, Nicolaides N, Markowitz S, Wilson JKV, Parsons RE, Jen J, Papadopoulos N, Peltomaki P, de la Chapelle A, Hamilton SR, Kinzler KW and Vogelstein B. (1995). Nature Genetics, 9, 48-54.
17. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, de la Chapelle A, Hamilton SR, Vogelstein B and Kinzler KW. (1996). Nature Med., 2, 169-174.
18. Lynch HT. (1993). Gasteroenterology, 104, 1535-1549.
19. Modrich P. (1997). J Biol. Chem., 272, 24727-24730.
20. Neijt JP. (1997). Textbook of Medical Oncology. Cavalli F, Hansen HH, Kaye SB, (eds). Martin Dunitz Ltd: London. pp. 87-115.
21. Nyce J. (1989). Cancer Res., 49, 5829-5836.
22. Prolla TA, Baker SM, Harris AC, Tsao J, Yao X, Bronner E, Zheng B, Gordon M, Reneker J, Arnheim N, Shibata D, Bradley A and Liskay RM. (1997). Nature Genet., 18, 276-279.
23. Reitmair AH, Redston M, Chun J, Chuang TCY, Bjerkness M, Cheng H, Hay K, Gallinger S, Bapat B and Mak TW. (1996). Cancer Res., 56, 3842-3849.
24. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, Moslein G, Baker SM, Liskay RM, Burgart LJ, Honchel R and Halling KC. (1996). Cancer Res., 56, 4836-4840.
25. Zingg J and Jones PA. (1997). Carcinogenesis, 18, 869-882.